Downregulation of these proteins inhibits DHX9 expression, suppresses proliferation and sensitizes Ewing sarcoma cells to doxorubicin treatment, revealing the importance of DHX9 alternative splicing in conferring chemosensitivity or chemoresistance [108]. This evidence concerns the gene DHX9 and Ewing sarcoma.